Evidence map›Paper›PMID 35182301›Full record

ReviewCurrent osteoporosis reports2022

Sfrp4 and the Biology of Cortical Bone.

Ruiying Chen, Roland Baron, Francesca Gori

Open access · greenAbstract readReview
In one paragraph

Review in Current osteoporosis reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Sfrp4 is required to maintain Ctsk-lineage periosteal stem cell niche function.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ruiying ChenDivision of Bone and Mineral Research, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.
Roland BaronDivision of Bone and Mineral Research, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.
Francesca GoriDivision of Bone and Mineral Research, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA. Francesca_gori@hsdm.harvard.edu.ORCID 0000-0001-5685-8303
Harvard University · US

Funding

R-Spondin3 as a target for anabolic bone therapyR01AR064724 · NIAMS · HARVARD MEDICAL SCHOOL · PI BARON, ROLAND E · 2014 to 2018
$2.7M
Biology of cortical bone of long bones and calvarium: Role of Sfrp4 in periosteal bone formationR01DE029615 · NIDCR · HARVARD MEDICAL SCHOOL · PI GORI, FRANCESCA · 2020 to 2024
$2.0M
Biology of cortical bone of long bones and calvarium. Role of Sfrp4 in the local regulation of Wnt signalingR56DE028299 · NIDCR · HARVARD MEDICAL SCHOOL · PI GORI, FRANCESCA · 2019 to 2019
$414k
NIAMS NIH HHS R01 AR064724NIDCR NIH HHS R01 DE029615NIDCR NIH HHS R56 DE028299
6 · The paper itself

Abstract

purpose of reviewPeriosteal apposition and endosteal remodeling regulate cortical bone expansion and thickness, both critical determinants of bone strength. Yet, the cellular characteristics and local or paracrine factors that regulate the periosteum and endosteum remain largely elusive. Here we discuss novel insights in cortical bone growth, expansion, and homeostasis, provided by the study of Secreted Frizzled Receptor Protein 4 (Sfrp4), a decoy receptor for Wnt ligands. RECENT

findingsSFRP4 loss-of function mutations cause Pyle disease, a rare skeletal disorder characterized by cortical bone thinning and increased fragility fractures despite increased trabecular bone density. On the endosteal surface, Sfrp4-mediated repression of non-canonical Wnt signaling regulates endosteal resorption. On the periosteum, Sfrp4 identifies as a critical functional mediator of periosteal stem cell/progenitor expansion and differentiation. Analysis of signaling pathways regulating skeletal stem cells/progenitors provides an opportunity to advance our understanding of the mechanisms involved in cortical bone biology.

Indexed as

Cortical BoneFrizzled ReceptorsBiologyCell DifferentiationHumansPeriosteumProto-Oncogene ProteinsSecreted Frizzled-Related ProteinsFrizzled ReceptorsProto-Oncogene ProteinsSecreted Frizzled-Related ProteinsSFRP4 protein, humanCathepsin K periosteal stem cellsCortical bonePeriosteumPyle diseaseSfrp4Wnt

Identifiers

PMID35182301
PMCPMC9098678
OpenAlexW4212808678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.